WntResearch has announced the appointment of Per Norlén as its new CEO. He replaces Pernilla Sandwall who has been CEO of the company since 2022. Norlén is essentially a doctor at Lund University and has worked for 20 years in various leading positions in the pharmaceutical industry and the biotechnology sector.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.067 SEK | -.--% | -.--% | -27.17% |
05-03 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-27.17% | 5.42M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.74% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- WNT Stock
- News WntResearch AB
- WntResearch Announces CEO Changes